Paper31097992
Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity.
Taniguchi T and 14 others. ACS Med Chem Lett, 2019. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity. Papers, record 31097992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31097992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11073607 | Fast microwave-assisted preparation of aryl and vinyl nitriles and the corresponding tetrazoles from organo-halides | J Org Chem | 2000 | https://conductscience.org/library/papers/11073607 | PubMed |
| 2 | 17606629 | Fer-mediated cortactin phosphorylation is associated with efficient fibroblast migration and is dependent on reactive oxygen species generation during integrin-mediated cell adhesion. | Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17606629 | PubMed |
| 3 | 19738202 | The tyrosine kinase Fer is a downstream target of the PLD-PA pathway that regulates cell migration. | Sci Signal | 2009 | https://conductscience.org/library/papers/19738202 | PubMed |
| 4 | 20345171 | A medicinal chemist's guide to molecular interactions. | J Med Chem | 2010 | https://conductscience.org/library/papers/20345171 | PubMed |
| 5 | 21705219 | Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 3: exploration of effective compounds in arthritis models. | Bioorg Med Chem Lett | 2011 | https://conductscience.org/library/papers/21705219 | PubMed |
| 6 | 23873028 | FER kinase promotes breast cancer metastasis by regulating α6- and β1-integrin-dependent cell adhesion and anoikis resistance. | Oncogene | 2013 | https://conductscience.org/library/papers/23873028 | PubMed |
| 7 | 28245430 | MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice. | Gastroenterology | 2017 | https://conductscience.org/library/papers/28245430 | PubMed |
| 8 | 29038547 | A novel Fer/FerT targeting compound selectively evokes metabolic stress and necrotic death in malignant cells. | Nat Commun | 2017 | https://conductscience.org/library/papers/29038547 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40707658 | Exosome- transported FER inhibitor suppresses progression of diffuse large B-cell lymphoma via regulating AJUBA/Hippo axis. | NPJ Precis Oncol | 2025 | https://conductscience.org/library/papers/40707658 | PubMed |
| 39707607 | Genetic variants of FER and SULF1 in the fibroblast-related genes are associated with non-small-cell lung cancer survival. | Int J Cancer | 2025 | https://conductscience.org/library/papers/39707607 | PubMed |
| 39105606 | An overview of pyridazin-3(2H)-one: a core for developing bioactive agents targeting cardiovascular diseases and cancer. | Future Med Chem | 2024 | https://conductscience.org/library/papers/39105606 | PubMed |
| 39015278 | Optimization of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors, Leading to the Potent DS08701581. | ACS Med Chem Lett | 2024 | https://conductscience.org/library/papers/39015278 | PubMed |
| 35938677 | Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology. | Am J Physiol Cell Physiol | 2022 | https://conductscience.org/library/papers/35938677 | PubMed |
| 35706047 | Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes. | Genome Med | 2022 | https://conductscience.org/library/papers/35706047 | PubMed |
| 31441171 | High-resolution structural analysis shows how different crystallographic environments can induce alternative modes of binding of a phosphotyrosine peptide to the SH2 domain of Fer tyrosine kinase. | Protein Sci | 2019 | https://conductscience.org/library/papers/31441171 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FER | 2241 | PubTator's text mining | https://conductscience.org/library/genes/2241 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31097992
GET https://conductscience.org/api/papers/v1/31097992/authors